Table 1 Preoperative patient characteristics
Variables | MR-group (n = 34) | Control-group (n = 43) | p value |
|---|---|---|---|
Age (years), mean ± SD | 52.0 ± 13.2 | 56.3 ± 10.9 | 0.126 |
Male, n (%) | 27 (79.4) | 38 (88.4) | 0.282 |
BMI, kg/m2, mean ± SD | 24.9 ± 4.5 | 26.9 ± 6.3 | 0.115 |
Ischemic cardiomyopathy, n (%) | 11 (32.4) | 28 (65.1) | 0.004 |
Non-ischemic dilated cardiomyopathy, n (%) | 23 (67.6) | 15 (34.9) | 0.004 |
Arterial hypertension, n (%) | 10 (29.4) | 23 (53.5) | 0.034 |
Diabetes mellitus, n (%) | 11 (32.4) | 14 (32.6) | 0.985 |
COPD > GOLD II, n (%) | 4 (11.8) | 10 (23.3) | 0.194 |
Atrial fibrillation, n (%) | 16 (47.1) | 23 (58.1) | 0.102 |
Previous stroke, n (%) | 4 (11.8) | 5 (11.6) | 0.985 |
Chronic renal failure, n (%) | 26 (76.5) | 26 (60.5) | 0.136 |
Previous hemodialysis, n (%) | 5 (14.7) | 6 (14.0) | 0.925 |
Serum creatinin level (mg/dl), mean ± SD | 1.6 ± 0.6 | 1.7 ± 0.7 | 0.279 |
Serum NT-proBNP level (pg/dl), mean ± SD | 10,336 ± 8360 | 9692 ± 8816 | 0.766 |
Destination therapy, n (%) | 12 (35.3) | 23 (53.5) | 0.113 |
Serum GOT level (U/l), mean ± SD | 73.8 ± 114.7 | 103.5 ± 237.1 | 0.482 |
Serum GPT level (U/l), mean ± SD | 80.1 ± 142.6 | 93.9 ± 159.2 | 0.691 |
Serum bilirubin level (mg/dl), mean ± SD | 1.3 ± 0.8 | 1.2 ± 0.8 | 0.547 |
Previous short-term MCS, n (%) | 9 (26.5) | 13 (30.2) | 0.717 |
Previous sternotomy, n (%) | 5 (14.7) | 16 (37.2) | 0.028 |
Previous CABG, n (%) | 3 (8.8) | 11 (25.6) | 0.026 |